Research Paper Volume 13, Issue 15 pp 19415—19441

Development and validation of an intra-tumor heterogeneity-related signature to predict prognosis of bladder cancer: a study based on single-cell RNA-seq

Validation of HRS. (A) A nomogram was plotted to visualize the HRS. (B, C) The calibration curves for 3- (B) and 5-year (C) OS prediction. (D–F) Kaplan-Meier survival analysis of HRS in TCGA (D), GSE13507 (E) and GSE32894 (F) cohorts. (G–I) The distribution of HRS in TCGA (G), GSE13507 (H) and GSE32894 (I). (J–L) The distribution of survival status in TCGA (J), GSE13507 (K) and GSE32894 (L).

Figure 4. Validation of HRS. (A) A nomogram was plotted to visualize the HRS. (B, C) The calibration curves for 3- (B) and 5-year (C) OS prediction. (DF) Kaplan-Meier survival analysis of HRS in TCGA (D), GSE13507 (E) and GSE32894 (F) cohorts. (GI) The distribution of HRS in TCGA (G), GSE13507 (H) and GSE32894 (I). (JL) The distribution of survival status in TCGA (J), GSE13507 (K) and GSE32894 (L).